Stocktoria
C4 Therapeutics, Inc. CCCC
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-10-02
C4 Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,551,510 | $21.0M |
| TWO SIGMA INVESTMENTS, LP | 3,035,634 | $8.0M |
| CITADEL ADVISORS LLC | 2,588,615 | $6.8M |
| RENAISSANCE TECHNOLOGIES LLC | 2,461,815 | $6.5M |
| MILLENNIUM MANAGEMENT LLC | 1,393,342 | $3.7M |
| D. E. Shaw & Co., Inc. | 1,060,331 | $2.8M |
| Point72 Asset Management, L.P. | 169,096 | $444,722 |
Source: SEC EDGAR filings · CIK 0001662579 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.